By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Cannabis NewsCannabis News
Aa
  • Cannabis
  • CBD
  • Science
  • Culture & Arts
  • Cannabis Press Releases
  • More
    • About Maryjanes Post
    • Cannabis Advertising
    • Cannabis Partnerships
Reading: China CBD Regulatory Report 2021: Yunnan and Heilongjiang Regulations Evolving – ResearchAndMarkets.com
Share
Aa
Cannabis NewsCannabis News
Search
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • About Maryjanes Post
    • Ambassador
    • Cannabis Partnerships
Follow US
  • Ad Choices
  • RSS Terms of Service
© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.
Cannabis News > Cannabis Press Releases > China CBD Regulatory Report 2021: Yunnan and Heilongjiang Regulations Evolving – ResearchAndMarkets.com
Cannabis Press Releases

China CBD Regulatory Report 2021: Yunnan and Heilongjiang Regulations Evolving – ResearchAndMarkets.com

Business Wire
Business Wire September 7, 2021
Updated 2021/09/07 at 3:44 PM
Share
SHARE

DUBLIN–(BUSINESS WIRE)–The “CBD Regulatory Report: Provincial Regulations Evolving in China” report has been added to ResearchAndMarkets.com’s offering.

logo Cannabis Media & PR

China has a long history of growing hemp for fibre and other uses such as in Chinese traditional herbs and in food. However, the legal field is a patchwork of different standards and government documents.

Currently, two provinces – Yunnan and Heilongjiang – have developed regulations for hemp and CBD, and Jilin province could be the third to do so. This report provides a comprehensive overview of the regulatory regime in China, looking at the general rules as well as the three provinces regulatory regimes.

- Advertisement -

Although unregulated, fibre hemp low in THC is grown in mainland China. The rules around hemp and CBD are complex and confusing, even more so with the individual provincial regulations that are currently emerging in the country. If you want to understand and gain insight into the regulatory regime for China and its provinces then this is the report for you. It offers a full overview of applicable restrictions – both in general and on a provincial level – in all areas including import/export, extracts and finished products.

The research is completely original and conducted by CBD-Intel’s multilingual legal analysis team using several sources, including online and offline resources and data, specialised legal software, interviews with key stakeholders and government officials, and via the collaboration with local lawyers and on-the-ground profession.

Key Topics Covered:

  • Outlook
  • Hemp
  • Extracts as finished product
  • Finished products
  • Import and export requirements
  • Medical cannabis
  • Recreational cannabis
  • Relevant laws
  • Relevant bodies

For more information about this report visit https://www.researchandmarkets.com/r/dvstxh

Cannabis Media & PR

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

You Might Also Like

Leafly Set to Join Russell 3000® and Russell 2000® Index

Proposed Settlement Reached in 2016 Class Action

Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022

IIPR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Innovative Industrial Properties, Inc. and Encourages Investors to Contact the Firm

TAGGED: Business Wire
Business Wire September 7, 2021
Share this Article
Twitter Reddit Email Copy Link
Previous Article Anebulo Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Next Article Global CBD Oil Market Trajectory & Analytics Report 2021 – ResearchAndMarkets.com

You Might Also Like

Leafly Set to Join Russell 3000® and Russell 2000® Index

June 24, 2022

Proposed Settlement Reached in 2016 Class Action

June 24, 2022

Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting

June 24, 2022

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022

June 23, 2022

Cannabis News and More

Work with an experienced cannabis media firm to provide your brand with the exposure it needs.

Cannabis Topics

  • Cannabis
  • Business
  • CBD
  • Cannabis Science
  • Culture & Arts

Company

  • About Maryjanes Post
  • Contact Cannabis Media
  • Contributor Guidelines

Terms of Use

  • TERMS
  • PRIVACY
  • CONTRIBUTOR AGREEMENT
  • DMCA

Resources

  • Write For UsNew
  • Cannabis Advertising
  • Cannabis Partnerships
  • Cannabis Press ReleaseNew
Cannabis NewsCannabis News
Follow US

© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.

Go to mobile version
Welcome Back!

Sign in to your account

Lost your password?